Inflammation in Coronary Atherosclerosis: Insights into Pathogenesis and Therapeutic Potential of Anti-Inflammatory...

Area of Science:

• Cardiovascular Medicine
• Immunology
• Pharmacology

Background:

• Atherosclerosis is a chronic inflammatory disease characterized by lipid accumulation and plaque formation in arteries.
• Inflammation, involving immune cells and pathways, is central to atherosclerosis development and progression.
• Anti-inflammatory drugs show promise in reducing cardiovascular events but face limitations in clinical application.

Purpose of the Study:

• To deepen the understanding of the inflammatory mechanisms underlying coronary atherosclerosis.
• To review and explore traditional and novel anti-inflammatory therapeutic strategies for coronary artery disease.
• To identify optimal patient profiles for maximizing the benefits of anti-inflammatory therapies.

Main Methods:

• Comprehensive literature review of studies on inflammation in atherosclerosis.
• Analysis of existing data on anti-inflammatory drug efficacy and limitations.
• Exploration of emerging and non-traditional anti-inflammatory approaches.

Main Results:

• Inflammation is a key driver of atherosclerosis, influencing plaque development and stability.
• Current anti-inflammatory therapies offer benefits but require careful patient selection and monitoring.
• Various traditional and novel anti-inflammatory interventions are being investigated.

Conclusions:

• A thorough understanding of inflammation in coronary atherosclerosis is crucial for effective treatment.
• Addressing limitations such as cost, side effects, and patient stratification is essential for wider clinical adoption of anti-inflammatory drugs.
• Further research into both established and novel anti-inflammatory approaches holds potential for improving outcomes in coronary artery disease.